Details: pack, label wording, sources, registration
Polifleks 0.9%, Solution
solution for infusion, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
6.6/10
Situational / acceptable
Details →
vetman assessment
Polifleks
×
0.9%, solution for infusion, human medicine
Assessed clinical scope Dog · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care setting Veterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score
6.6/10
Situational / acceptable
Evidence confidence: Medium
Georgia: Yes, human · № რ-046137, რ-046138, რ-046139 · Verified on 16 Oct 2026
Off-label use
A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.
Regulatory and scientific credibility 5.5/10
The exact 0.9% human infusion has a sourced current Georgian registration and identifiable manufacturer, strength and IV route, while exhaustive current checks record it as not registered in EU/EEA, GB or US. Veterinary administration is off-label and no exact-product veterinary dossier was found.
Clinical efficacy 6.5/10
Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.
Safety and tolerability 6.5/10
Class safety is well characterised, but a public exact-product dossier was not found. Main risks are dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema, contamination and line complications; renal, cardiac and oligoanuric patients, cats and small dogs require particularly tight volume control.
Clinical practicality 8.5/10
A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.
Full-course cost-effectiveness -
Price was not assessed and is excluded from the overall score.
Important safety and use flags
Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached. Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid. At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient. Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts. Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility. Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends. Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container. Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use. Assessment sources +
Close
Cat
Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid
6.6/10
Situational / acceptable
Details →
vetman assessment
Polifleks
×
0.9%, solution for infusion, human medicine
Assessed clinical scope Cat · Selected IV 0.9% sodium chloride for extracellular-volume replacement, chloride-responsive metabolic alkalosis, or a compatible injectable-drug diluent/flush; not default maintenance, free-water replacement or routine resuscitation fluid · Intravenous
Care setting Veterinary clinic or hospital after individual fluid prescription, using a pump or other volume-limiting device and repeated perfusion, body-weight, input/output, electrolyte and acid-base reassessment
vetman score
6.6/10
Situational / acceptable
Evidence confidence: Medium
Georgia: Yes, human · № რ-046137, რ-046138, რ-046139 · Verified on 16 Oct 2026
Off-label use
A dependable clinic fluid and diluent when 154 mmol/L sodium and chloride, chloride replacement or specific compatibility is wanted. It should be prescribed like a drug, not continued by habit: balanced crystalloids are usually preferable for routine resuscitation, and volume, chloride, sodium and acid-base effects require reassessment.
Regulatory and scientific credibility 5.5/10
The exact 0.9% human infusion has a sourced current Georgian registration and identifiable manufacturer, strength and IV route, while exhaustive current checks record it as not registered in EU/EEA, GB or US. Veterinary administration is off-label and no exact-product veterinary dossier was found.
Clinical efficacy 6.5/10
Sodium chloride 0.9% reliably expands extracellular volume and supplies sodium and chloride, and it is useful when its composition or compatibility is specifically wanted. It is not physiologically balanced: current dog/cat guidance generally favours buffered balanced crystalloids for routine resuscitation and warns that high chloride exposure may impair acid-base and renal physiology; veterinary comparative outcome evidence remains limited.
Safety and tolerability 6.5/10
Class safety is well characterised, but a public exact-product dossier was not found. Main risks are dose- and rate-related fluid overload, hypernatraemia, hyperchloraemia, acid-base disturbance, edema, contamination and line complications; renal, cardiac and oligoanuric patients, cats and small dogs require particularly tight volume control.
Clinical practicality 8.5/10
A ready-to-use sterile isotonic solution fits standard IV sets, pumps and drug-dilution workflows and permits weight-based boluses or infusions. Practicality depends on selecting a bag appropriate to patient size, counting flushes and drug carriers in the total fluid prescription, maintaining asepsis, confirming additive compatibility and discarding compromised or time-expired containers.
Full-course cost-effectiveness -
Price was not assessed and is excluded from the overall score.
Important safety and use flags
Do not select 0.9% saline as routine ongoing fluid in existing hypernatraemia or hyperchloraemia. Measure sodium and corrected chloride, define the desired direction and rate of change, and switch or stop when the compositional target is reached. Fluid overload can be life-threatening and is usually iatrogenic. Use extra caution in heart, kidney or liver disease, oliguria/anuria, pulmonary or peripheral edema, cats and small dogs; count every bolus, infusion, flush, drug carrier, enteral input and ongoing loss, and stop non-beneficial fluid. At 154 mmol/L chloride, large or prolonged volumes can raise chloride and contribute to hyperchloraemic metabolic acidosis and possibly renal vasoconstriction. Recheck electrolytes, blood gas/acid-base status, creatinine, urine output and clinical perfusion; use a buffered balanced crystalloid when it better matches the patient. Do not use 0.9% saline automatically as maintenance or free-water replacement. Its sodium and chloride content exceeds maintenance needs, and sodium disorders require a calculated correction plan with frequent reassessment to avoid dangerous neurologic shifts. Before adding or co-infusing any medicine, confirm compatibility, final concentration, diluent, route, stability and line requirements from that medicine’s own current instructions. Inspect for haze, colour change, particles or precipitate; an isotonic carrier is not proof of chemical compatibility. Prescribe a patient-specific endpoint and reassessment interval rather than a fixed universal rate. During resuscitation give measured aliquots and reassess perfusion after each; during ongoing therapy track body weight, respiratory rate/effort, edema, input/output, blood pressure and laboratory trends. Use an intact, clear, particle-free container, a patient-size-appropriate bag and an accurate pump or volume-limiting device. Maintain catheter and port asepsis, follow the exact product’s post-opening limit, never pool residual fluid between patients, and discard a contaminated, damaged or expired container. Pack size, container material, ports, overwrap, storage and post-opening instructions can differ among these eight exact products. The shared score does not imply interchangeability for pressure infusion, drug compounding, blood-line use or a specific delivery device; verify the exact insert before use. Assessment sources +
Close
Administration route
Intravenous
Registration
Georgia
Yes, human
In force until 11 Aug 2031
Human (Ministry of Health, RAMA)
In the register: პოლიფლექსი 0.9%, საინფუზიო ხსნარი
№ რ-046137, რ-046138, რ-046139
Verified on: 16 Oct 2026
EU
No
UK
No
US
No
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
